Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Cramer's Mad Money Recap: Tesla, Apple, Google
By Scott Rutt
Jul 23, 2021 9:27 PM EDT
Latest News
JIM CRAMER
Cramer's Mad Money Recap: Chipotle, Carnival, Wells Fargo
By Scott Rutt
Jul 20, 2021 8:35 PM EDT
PRESS RELEASES
AbbVie Provides Update Regarding RINVOQ® (upadacitinib) For The Treatment Of Moderate To Severe Atopic Dermatitis In The U.S.
By PR Newswire
Jul 16, 2021 8:30 AM EDT
JIM CRAMER
Morning Bell With Jim Cramer: Boeing and AbbVie
By Rob Lenihan
Jul 14, 2021 10:02 AM EDT
INVESTING
Stock Market Today With Jim Cramer: AbbVie Rises, Reddit Lauds AMC
By Tony Owusu
Jul 13, 2021 3:52 PM EDT
Video
TheStreet Live Recap: Everything Jim Cramer Is Watching 7/13/21
Jul 13, 2021 2:02 PM EDT
Video
Why Jim Cramer Doesn't Understand the Run in AbbVie Stock
Jul 13, 2021 12:59 PM EDT
JIM CRAMER
Video: Jim Cramer on JPMorgan, Goldman Sachs, PepsiCo, Boeing, CPI
By Daniel Kuhn
Jul 13, 2021 9:50 AM EDT
PRESS RELEASES
AbbVie To Host Second-Quarter 2021 Earnings Conference Call
By PR Newswire
Jul 7, 2021 8:00 AM EDT
INVESTING
AbbVie Slips on FDA Delay in Arthritis-Drug Action Dates
By Rob Lenihan
Jun 25, 2021 10:42 AM EDT
PRESS RELEASES
CHMP Recommends Approval Of RINVOQ® (upadacitinib) For The Treatment Of Atopic Dermatitis
By PR Newswire
Jun 25, 2021 2:30 AM EDT
PRESS RELEASES
AbbVie Exercises Right To Acquire TeneoOne And Lead Asset TNB-383B For The Potential Treatment Of Relapsed Or Refractory Multiple Myeloma
By PR Newswire
Jun 24, 2021 8:00 AM EDT
PRESS RELEASES
AbbVie Declares Quarterly Dividend
By PR Newswire
Jun 17, 2021 6:29 PM EDT
PRESS RELEASES
Zhongchao Inc. Partners With A Subsidiary Of AbbVie Inc. (NYSE: ABBV) For Medical Education Services
By PR Newswire
Jun 16, 2021 6:30 AM EDT
JIM CRAMER
Cramer's Mad Money Recap: Game Plan
By Scott Rutt
Jun 11, 2021 8:27 PM EDT
PRESS RELEASES
Allergan Aesthetics And BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories At The Forefront In New Campaign
By PR Newswire
Jun 8, 2021 8:45 AM EDT
INVESTING
Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher
By Alicia Stein
Jun 2, 2021 6:01 PM EDT
INVESTING
AbbVie Faces U.S. Senate Pressure Over Tax Payments
By Tony Owusu
Jun 2, 2021 11:24 AM EDT
PRESS RELEASES
AbbVie To Present At Bernstein's 37th Annual Strategic Decisions Conference
By PR Newswire
May 26, 2021 8:15 AM EDT
PRESS RELEASES
The Lancet Publishes Results From Pivotal Global Phase 3 Program Evaluating RINVOQ® (upadacitinib) In Atopic Dermatitis
By PR Newswire
May 24, 2021 8:45 AM EDT
PRESS RELEASES
AbbVie To Present At The UBS Global Healthcare Virtual Conference
By PR Newswire
May 20, 2021 8:00 AM EDT
PRESS RELEASES
SOLITON INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Soliton, Inc. - SOLY
By Business Wire
May 12, 2021 5:27 PM EDT
PRESS RELEASES
AbbVie To Present At The RBC Capital Markets Global Healthcare Conference
By PR Newswire
May 12, 2021 8:00 AM EDT
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Soliton, Inc.
By PR Newswire
May 10, 2021 4:24 PM EDT
PRESS RELEASES
Allergan Aesthetics To Acquire Soliton, Expanding Body Contouring Portfolio
By PR Newswire
May 10, 2021 8:30 AM EDT
